– USA, MA – Arch Therapeutics, Inc. (OTC: ARTH), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced the appointment of Larry Hicks to its Board of Directors.
“I am delighted that Larry has joined the Board at Arch. He has an unusual breadth and depth of experience in areas of particular importance to us. I am confident that his proven capabilities to drive sales, coupled with his passion for the Company’s purpose, will prove invaluable to Arch as we continue to execute our commercialization plan.” said CEO, Dr. Terry Norchi.
About Larry Hicks
Larry Hicks has over 30 years of medical device experience with an established track record of success in commercialization, operations, and creating shareholder value. Mr. Hicks is currently the CEO of Healthcare Components Group, a global manufacturer of OEM and replacement parts used for the manufacture and repair of medical devices. He has held medical device leadership roles at ACMI, Karl Storz Endoscopy, and NeuroTherm.
Mr. Hicks said, “Arch Therapeutics’ technology has the potential to dramatically improve outcomes for millions of patients, and I am honored to have the opportunity to contribute to their growth as a member of the Board. I am confident that Arch will achieve great success.”
About Arch Therapeutics, Inc.
Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding, control leaking and manage wounds during surgery, trauma, and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform to make care faster and safer for patients. Arch has received regulatory authorization to market AC5 Advanced Wound System and AC5 Topical Hemostat as medical devices in the United States and Europe, respectively. Arch’s development stage product candidates include AC5-G, AC5-V, and AC5 Surgical Hemostat, among others.
For more information: https://www.archtherapeutics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.